Navigation Links
Spectros Launches OnCall Wireless Remote Access for T-Stat
Date:6/18/2012

PORTOLA VALLEY, Calif., June 18, 2012 /PRNewswire/ -- Spectros Corporation announces the successful launch of OnCall wireless remote access for viewing real-time patient results on T-Stat white light tissue oximeters. 

OnCall changes the standard of healthcare by improving patient monitoring and decreasing the delayed response time to critical care events. Surgeons have long awaited an easy and simple approach to remote monitoring that is not limited to a specific phone application, but available with any wireless connection that may be available. The program was developed by Spectros Corporation and is compliant with all HIPAA requirements to insure safety and efficacy. "Human error and lack of communication between health care providers is a variable that cannot always be controlled. Removing this factor reduces failure rates and provides more confidence in both patients and surgeons." – Elizabeth van Thillo Rohlff, Director of Marketing and Sales.

The OnCall remote monitoring feature is easily added to any existing T-Stat VLS tissue oximeter or built into any of the other broadband optical patient monitors being developed by leading optical engineers at Spectros Corp. The reconstructive plastic surgery market is the first to adopt the OnCall system and will be followed by the gastroenterology and critical care fields currently using T-Stat.

"This, coupled with our broadband technology, puts us well beyond our competitors,*" said van Thillo Rohlff. "Soon all patient monitors will be moving towards this model as the standard of care continues to advance and adopt new and progressive technologies. Remote patient monitoring is the future of patient monitoring and Spectros is proud to be part of it. Today's common smart phone is tomorrow's patient monitoring access point and we are proud to be helping healthcare teams by developing an easy to use and reliable system."

About Spectros

Spectros markets advanced molecular devices that shed light on ischemia and cancer. Spectros is also developing molecular imaging contrast agents for surgical guidance during breast and prostate cancer surgeries, currently undergoing phase I/II clinical trials.  Spectros is a venture-supported concern.

(Note:  Forward-looking statements do not constitute an offer for investment nor a guarantee of future events or returns.  Certain applications described above have not been reviewed by the FDA, and are therefore labeled for investigational use only.  T-Stat is a trademark of Spectros.)

*INVOS is a trademark of Somanetics and Covidien. FORE-SIGHT is a trademark of CAS Medical. T.Ox is trademark of ViOptix.

For further information, visit www.spectros.com.  

Web Site: http://www.spectros.com

CONTACT: Elizabeth van Thillo Rohlff, elizabeth@spectros.com.


'/>"/>
SOURCE Spectros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. Molecular spectroscopy tracks living mammalian cells in real time as they differentiate
2. LAMIS -- a green chemistry alternative for laser spectroscopy
3. NIST launches new website to educate industry about alternatives to mercury thermometers
4. PuraMed BioScience®, Inc., Launches a Marketing Blitz for LipiGesic® M, Its Clinically-Tested Migraine Pain Reliever in the Denver, CO Region to Coincide with the NACDSs Marketplace 2012 Trade Convention
5. NineSigma Launches NineSights, the Worlds First Open Innovation Social Media Destination for Innovation Seekers and Solution Providers
6. MindSpec launches online Autism Reading Room
7. Wiley-Blackwell launches new open-access journal: Food Science & Nutrition
8. WanderID Launches Breakthrough ID Product for Children, Seniors
9. Thomson Reuters Launches Life Sciences Partner Ecosystem to Drive Collaborative R&D Drug Processes
10. Clinical trial launches to see whether vitamin D helps treat multiple sclerosis
11. Elsevier launches new journal Algal Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2017)... 2017 Summary This report provides all ... partnering interests and activities since 2010. ... Read the full report: ... 2010 report provides an in-depth insight into the partnering activity ... On demand company reports are prepared upon purchase to ...
(Date:3/2/2017)... March 2, 2017 Who risk to be ... Download the full report: https://www.reportbuyer.com/product/4313699/ WILL ... SENSOR FIELD? Fingerprint sensors using capacitive technology represent ... sensor vendor Idex forecasts an increase of 360% of ... and of the fingerprint sensor market between 2014 and ...
(Date:3/1/2017)... 2017  Aware, Inc. (NASDAQ: AWRE), a leading supplier ... P. Moberg has resigned, effective March 3, 2017, ... Officer and Treasurer of Aware citing a desire to ... member of the Board of Directors of Aware. ... Officer and co-President, General Counsel has been named Chief ...
Breaking Biology News(10 mins):
(Date:3/27/2017)... Connecticut (PRWEB) , ... March 27, 2017 , ... ... dedicated to accelerating the fight against cancer, autoimmune disease and more through a ... the single-cell metabolomics and proteomics analysis platform developed in the laboratory of ...
(Date:3/27/2017)... Infectex Ltd., a Russian portfolio company of Maxwell Biotech Venture Fund (MBVF), today ... standard drug therapy regimen in patients with multidrug-resistant pulmonary tuberculosis (MDR-TB). SQ109 is a ... ) and the US National Institutes of Health. Continue ... ... ...
(Date:3/27/2017)... 2017 The new research portal will ... of reports on Valero Energy , offering extensive market ... industries. ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO) The latest trend ... green. Ethanol today, even though touted as a green alternative ...
(Date:3/27/2017)... March 27, 2017  Trovagene, Inc. (NASDAQ: TROV), a ... Executive Officer, Bill Welch , will be presenting ... at 9:00 AM EDT at the Essex House in ... and Chief Scientific Officer, Mark Erlander , Ph.D., ... the conference.   The presentation will be webcast ...
Breaking Biology Technology: